» Articles » PMID: 38220184

Cigarette Smoking and Atherosclerotic Cardiovascular Disease

Overview
Date 2024 Jan 14
PMID 38220184
Authors
Affiliations
Soon will be listed here.
Abstract

The detrimental effects of cigarette smoking on cardiovascular health, particularly atherosclerosis and thrombosis, are well established, and more detailed mechanisms continue to emerge. As the fundamental pathophysiology of the adverse effects of smoking, endothelial dysfunction, inflammation, and thrombosis are considered to be particularly important. Cigarette smoke induces endothelial dysfunction, leading to impaired vascular dilation and hemostasis regulation. Factors contributing to endothelial dysfunction include reduced bioavailability of nitric oxide, increased levels of superoxide anion, and endothelin release. Chronic inflammation of the vascular wall is a central pathogenesis of smoking-induced atherosclerosis. Smoking systemically elevates inflammatory markers and induces the expression of adhesion molecules and cytokines in various tissues. Pattern recognition receptors and damage-associated molecular patterns play crucial roles in the mechanism underlying smoking-induced inflammation. Smoking-induced DNA damage and activation of innate immunity, such as the NLRP3 inflammasome, cyclic GMP-AMP synthase (cGAS)-stimulator of interferon genes (STING) pathway, and Toll-like receptor 9, are shown to amplify inflammatory cytokine expression. Cigarette smoke-induced oxidative stress and inflammation influence platelet adhesion, aggregation, and coagulation via adhesion molecule upregulation. Furthermore, it affects the coagulation cascade and fibrinolysis balance, causing thrombus formation. Matrix metalloproteinases contribute to plaque vulnerability and atherothrombotic events. The impact of smoking on inflammatory cells and adhesion molecules further intensifies the risk of atherothrombosis. Collectively, exposure to cigarette smoke exerts profound effects on endothelial function, inflammation, and thrombosis, contributing to the development and progression of atherosclerosis and atherothrombotic cardiovascular diseases. Understanding these intricate mechanisms highlights the urgent need for smoking cessation to protect cardiovascular health. This comprehensive review investigates the multifaceted mechanisms through which smoking contributes to these life-threatening conditions.

Citing Articles

Aerosolized nicotine-free e-liquid base constituents exacerbates mitochondrial dysfunction and endothelial glycocalyx shedding via the AKT/GSK3β-mPTP pathway in lung injury models.

Dai Z, Xie B, Jiang C, Peng Y, Lin J, Chen Q Respir Res. 2025; 26(1):82.

PMID: 40025534 PMC: 11871641. DOI: 10.1186/s12931-025-03155-3.


Multidisciplinary Clinical Study on Retinal, Circulatory, and Respiratory Damage in Smoking-Dependent Subjects.

Nebbioso M, Vestri A, Gharbiya M, DAndrea M, Calbucci M, Pasqualotto F Medicina (Kaunas). 2025; 61(2).

PMID: 40005463 PMC: 11857288. DOI: 10.3390/medicina61020347.


Cigarette Smoking Patterns Among Racial and Ethnic Groups With Chronic Lung Diseases During the COVID-19 Pandemic.

Seegulam V, Washington C, Surendran P, Falise A, Gomez-Manjarres D, Lopez-Quintero C AJPM Focus. 2025; 4(3):100310.

PMID: 39963202 PMC: 11830302. DOI: 10.1016/j.focus.2024.100310.


TCF7L2 as a target of peripheral artery disease in patients with type 2 diabetes: A 2-sample Mendelian randomization and bioinformatics study.

Liu J, Liu X, Rao R, Li W Medicine (Baltimore). 2025; 104(7):e41431.

PMID: 39960897 PMC: 11835089. DOI: 10.1097/MD.0000000000041431.


Atherosclerosis: A Comprehensive Review of Molecular Factors and Mechanisms.

Tasouli-Drakou V, Ogurek I, Shaikh T, Ringor M, DiCaro M, Lei K Int J Mol Sci. 2025; 26(3).

PMID: 39941130 PMC: 11818631. DOI: 10.3390/ijms26031364.


References
1.
Takahashi M . NLRP3 inflammasome as a key driver of vascular disease. Cardiovasc Res. 2021; 118(2):372-385. DOI: 10.1093/cvr/cvab010. View

2.
Duewell P, Kono H, Rayner K, Sirois C, Vladimer G, Bauernfeind F . NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals. Nature. 2010; 464(7293):1357-61. PMC: 2946640. DOI: 10.1038/nature08938. View

3.
Roshan M, Tambo A, Pace N . The Role of TLR2, TLR4, and TLR9 in the Pathogenesis of Atherosclerosis. Int J Inflam. 2016; 2016:1532832. PMC: 5067326. DOI: 10.1155/2016/1532832. View

4.
Hendrikx T, Jeurissen M, van Gorp P, Gijbels M, Walenbergh S, Houben T . Bone marrow-specific caspase-1/11 deficiency inhibits atherosclerosis development in Ldlr(-/-) mice. FEBS J. 2015; 282(12):2327-38. DOI: 10.1111/febs.13279. View

5.
Lavi S, Prasad A, Yang E, Mathew V, Simari R, Rihal C . Smoking is associated with epicardial coronary endothelial dysfunction and elevated white blood cell count in patients with chest pain and early coronary artery disease. Circulation. 2007; 115(20):2621-7. DOI: 10.1161/CIRCULATIONAHA.106.641654. View